Multiple Myeloma Specialist

Hear directly from experts who specialize in multiple myeloma.

Multiple myeloma is a cancer that starts in a type of white blood cell called plasma cells. While it is not curable, it is very treatable with a lot of research and clinical trials focused on trying to extend life on the path to a cure.

Explore interviews with medical experts who specialize in multiple myeloma, including oncologists who talk about latest in treatment trends amid a rapidly-shifting landscape that seems to favor new combinations. Also learn more about CAR T cell therapy and bispecifics in multiple myeloma.

Oncologists

Valarie Traynham and Dr. Shakira Grant

Research on Black Myeloma Patients, Access & Disparities



Patient advocate Valarie Traynham and Dr. Shakira Grant discuss the barriers many Black patients face, how it impacts their care, and what can be done to help improve their outcomes.


Irene Ghobrial, MD



Role: Clinical investigator and professor of hematological oncology
Focus: Multiple myeloma, Waldenström’s Macroglobulinemia, early screening, clinical trials
Provider:Dana-Farber Cancer Institute (Boston)

James Berenson, MD



Oncologist: Specializing in myeloma and other blood and bone disorders
Experience: 35+ years
Institution: Berenson Cancer Center
Dr. Joseph Mikhael

Joseph Mikhael, MD



Role: Dir. Myeloma Research, CMO at International Myeloma Foundation (IMF)
Focus: Multiple myeloma
Provider: TGen/City of Hope

Nina Shah, MD



Role: Hematologist-oncologist, researcher
Focus: Multiple Myeloma
Institution: University of California, San Francisco (UCSF)